I-MASK+ Protocol

The Front Line COVID-19 Critical Care Alliance has now developed a preventive and early outpatient combination treatment protocol for COVID-19 called I-MASK+. The “I” in this protocol for ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.

Medical Evidence

... scientific studies that provide the medical evidence in support of the individual medical therapies that make up our MATH+ Hospital Treatment Protocol for Covid-19 (and in parts also our I-MASK+ Protocol):

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

In summary, based on the existing and cumulative body of evidence, we recommend the use of ivermectin in both prophylaxis and treatment for COVID-19. In the presence of a global COVID-19 surge, the widespread use of this safe, inexpensive, and effective intervention would lead to a drastic reduction in transmission rates and the morbidity and mortality in mild, moderate, and even severe disease phases.

Optional Medicines for the Treatment of COVID-19

A founding principle underlying our I-MASK+ and MATH+ treatment protocols is that they evolve in accordance with both emerging therapeutic trials evidence as well as new pathophysiologic insights. When sufficient supportive evidence for a new therapeutic against COVID-19 emerges, we first add these medicines as “optional” components until such a time when we can better clarify their additive or synergistic efficacy to the existing core therapies.

An overview of the MATH+, I-MASK+ and I-RECOVER Protocols

This is our recommended approach to COVID-19 based on the best (and most recent) literature. This is a highly dynamic topic; therefore, we will be updating the guideline as new information emerges. Please check on the FLCCC Alliance website for updated versions of this protocol.

Real World Evidence? I-MASK+ Protocol: Ivermectin Key for Prophylaxis and Early Treatment of COVID-19

The FLCC is best known for its MATH+ COVID-19 treatment protocol. On October 14, TrialSite reported that this protocol included an Ivermectin option for prevention and early treatment of COVID-19. On October 31, the group formalized a new protocol for both prevention and early treatment of COVID-19, this time dubbed, I-MASK+. The “I” stands for Ivermectin, which is now the key ingredient in the protocol rather than an option.